CMS April 2026 DMEPOS Prior Auth Expansion:
What 7 New HCPCS Codes Mean for Your DME Business

The CMS prior authorization expansion hitting on April 13, 2026 is not a minor update. Seven new HCPCS codes are being added to the Required Prior Authorization List — expanding the list to 74+ DMEPOS items that now require advance approval before claim submission. For DME companies already stretched managing prior authorizations on 67 items, these seven new codes will touch orthosis and pneumatic compression device workflows that many providers handle across multiple product lines.

This article breaks down exactly what changed, which product categories are affected, what the new timelines require, and how DME providers can prepare their operational workflows — with specific attention to the 90% exemption path that CMS is quietly offering to companies that can prove they're doing PA right.

What's Changing on April 13, 2026

On January 13, 2026, CMS published its final rule expanding the Required Prior Authorization List for DMEPOS suppliers. Seven new codes, effective April 13, 2026, are being added to the list that already includes oxygen, certain orthoses, diabetic shoes, and compression garments. Two of these codes are pneumatic compression devices (PCDs), and five are orthosis codes covering multiple lower extremity support categories.

The 7 New HCPCS Codes

These codes represent product categories with documented improper payment rates. The CMS Comprehensive Error Rate Testing (CERT) program identified orthoses among the top 20 DMEPOS service types with improper payments. The pneumatic compression devices were added due to historical error rates and concerns about unnecessary utilization.

Why CMS Added These Codes

CMS does not expand prior authorization requirements lightly. Each addition represents a calculated decision that the administrative burden of pre-approval is justified by the improper payment risk. For these seven codes, the justification is documented in the regulatory analysis:

Orthoses (L0651, L1844, L1846, L1852, L1932): CMS's CERT program identified orthosis codes among the highest-error categories in DMEPOS claims. The errors ranged from medical necessity issues (patient does not qualify for the specific orthosis type) to documentation gaps (missing physician orders, insufficient clinical justification). By requiring prior authorization, CMS can validate medical necessity before payment, reducing downstream denials and overpayments.

Pneumatic Compression Devices (E0651, E0652): These devices have seen elevated error rates related to unnecessary utilization and lack of clinical justification. PCDs are expensive — average Medicare reimbursement ranges from $3,000–$5,000 per unit — and are sometimes billed without adequate documentation of lymphedema or venous insufficiency. Prior authorization serves as a gating mechanism to ensure medical appropriateness before the device ships.

The New Timeline Requirements

CMS has specific turnaround requirements for DME MACs (Medicare Administrative Contractors) when handling prior authorization requests. Understanding these timelines is critical for planning your internal workflow:

• Standard PA Review Window: DME MACs must complete review within 5 business days from the date of receipt of a complete submission, not to exceed 7 calendar days.
• Pneumatic Compression Device PA Validity: Once approved, a PCD prior authorization decision is valid for 60 calendar days from the date of approval. Other items follow the standard validity timelines established by CMS.
• Resubmission Timeline: If a PA request is denied or returned as incomplete, resubmissions follow the same 5/7-day timeline. There is no extended grace period for resubmissions.
• Appeals Timeline: Denied prior authorizations can be appealed through CMS's standard appeals process, but this requires separate action and does not halt the patient's clinical timeline or your billing timeline.

The practical implication: you must submit clean, complete documentation on the first attempt. Incomplete submissions that get returned consume precious time, and the patient's need for equipment does not pause while you gather missing documents.

How This Impacts DME Providers

The seven new codes will affect DME companies in different ways depending on their product mix. If you specialize in orthoses or pneumatic compression therapy, the impact is direct. If you carry multiple product lines, the impact is distributed across intake, order management, billing, and customer service functions.

Operational Impact: Your billing team now needs to flag seven additional item codes against the CMS PA list at the point of intake or order entry. For companies using manual processes or spreadsheet tracking, this means seven more rows to check, seven more payer portals to navigate, and seven more categories of documentation to assemble. For companies with automation, the impact is a one-time update to the rules engine.

Cash Flow Impact: Prior authorization necessarily delays claim submission. For orthoses, the delay is typically 5–7 days for approval, then the equipment ships, then the claim is submitted. For PCDs, the 60-day validity window means you can batch authorizations and delay claim submission to optimize reimbursement timing — but it also means longer revenue cycle times if you are not batching deliberately.

Documentation Burden: Orthoses and PCDs both require strong clinical documentation. For orthoses, you need physician orders, medical history confirming the diagnosis, and any prior authorization from commercial payers. For PCDs, you need diagnosis documentation proving lymphedema or venous insufficiency, often supplemented by physician clinical notes. If your intake process does not systematically capture this documentation, prior authorization will expose those gaps.

Staff Training: Your revenue cycle team needs to understand what makes a PCD or orthosis prior authorization complete from a payer perspective. Each payer has slightly different documentation requirements. Without clear internal documentation of these requirements, you will see resubmissions and denials that could have been prevented.

The 90% Exemption Path

Buried in CMS guidance is an opportunity that many DME providers miss entirely. CMS's Prior Authorization Exemption Program allows DMEPOS suppliers that achieve a 90% or higher prior authorization affirmation rate to apply for exemption from prior authorization requirements — for the specific items where they've demonstrated that level of compliance.

Here's how it works: If your company obtains prior authorizations for orthosis codes and achieves a 90%+ affirmation rate (meaning 90% of your submitted PAs are approved), CMS will grant you an exemption. You are then permitted to submit claims for those orthosis items without obtaining prior authorization first — until your affirmation rate drops below 90%, at which point CMS provides 60 days notice before withdrawing the exemption.

This creates a clear incentive structure: nail your prior authorizations, and you get to skip doing them. The path to that 90% threshold is operational excellence — accurate documentation, clean submissions, systematic denial analysis, and rapid resubmissions when needed. Which, not coincidentally, is what workflow automation is designed to deliver.

How to Prepare: Automated PA Workflows

Preparing for April 13, 2026 means ensuring your organization can reliably obtain prior authorizations for these seven new codes while maintaining accuracy on the existing 67 codes already requiring PA. Here's how to structure your preparation:

1. Update Your PA Requirements Matrix

Create a definitive list of CMS PA requirements by item code and by payer. Most DME companies maintain separate requirements for Medicare vs. commercial insurance. Your matrix should specify, for each code and payer combination: required documentation, submission method (portal, FHIR API, fax), processing timeline, and validity period. This becomes the master reference for all intake and billing staff.

2. Automate PA Trigger Detection

When a new order arrives in your system, automation should immediately check the item code against your PA requirements matrix. If the code requires PA, flag the order automatically. Your staff should not have to remember which codes require PA — the system should tell them. This is where most manual processes fail: relying on staff memory or manual list checking introduces systematic gaps.

3. Build Documentation Collection Into Intake

For orthoses and PCDs, documentation quality drives PA approval rates. Your intake process should prompt staff to collect specific documents upfront: physician orders, diagnosis codes, clinical justification, face-to-face encounter documentation (if required), and any prior payer denials or approvals. For PCDs specifically, ensure you capture the treating physician's assessment of lymphedema or venous insufficiency severity.

4. Implement Payer-Specific Submission Validation

Before submitting a PA request, your system should validate completeness against payer-specific requirements. HealthSpring's orthosis requirements differ from Humana's. Medicare's PA documentation differs from commercial Medicaid. A pre-submission validation step prevents the most common PA failures: incomplete submissions that get returned, consuming time and delaying approval.

5. Set Up Real-Time Status Monitoring

Once submitted, a PA request should be tracked automatically. Your system should monitor for approvals, monitor for denials, and escalate exceptions when a PA approaches the 7-day deadline without approval. This prevents the scenario where a PA gets lost in an inbox and your order ships without authorization.

6. Create a Denial Management Workflow

Not every PA will be approved on first submission. When a denial comes back, it should route automatically to the appropriate team member with the denial reason and recommended next steps. Was it missing documentation? Medical necessity issue? Coding error? Your system should categorize the denial, suggest corrections, and track the resubmission attempt.

The organizations hitting that 90% affirmation rate threshold are not doing something magical. They are executing these six functions systematically, automatically, and repeatedly. Workflow automation is how you achieve this consistency at scale.

What to Do Right Now

The April 13, 2026 deadline is two weeks away as of this writing. Here is the minimal checklist to ensure compliance and avoid avoidable claim denials:

• Audit your current tracking. Do you know which of the seven new codes your company bills regularly? For each code, do you know the documentation requirements by payer? If not, you have a gap to close immediately.
• Update your order entry system or checklist. Add the seven new codes to any PA requirement list or checklist your team uses at intake. This prevents orders from slipping through without PA.
• Communicate the change to your intake and billing teams. Make sure everyone handling new orders or claim submission understands that these items now require prior authorization. Provide payer-specific documentation requirements by code.
• Map your current affirmation rate. If you can pull historical PA data, calculate your affirmation rate for existing items by payer. This baseline tells you which payers you work smoothly with and which ones are problem areas for resubmissions.
• Prioritize the orthosis codes. Orthoses are high-volume in many DME practices. Ensuring you are submitting complete orthosis PAs from day one will prevent a wave of denials on April 13.

Frequently Asked Questions

Do prior authorizations for these items cost extra?

No. Prior authorization is a Medicare requirement, not a payer fee. DME MACs do not charge suppliers for obtaining prior authorization. However, the time your staff invests in assembling documentation and tracking submissions has an internal cost. This is the argument for automation — it reduces the labor cost of staying compliant.

Can we submit prior authorizations before April 13?

Yes. CMS allows prior authorization requests to be submitted starting March 30, 2026 for dates of service on or after April 13, 2026. This gives you a two-week window to start the process early if you have upcoming orders lined up.

What happens if we submit a claim without getting PA first?

The claim will be denied. DME MACs are instructed to deny any claim for these items if prior authorization was not obtained. You can appeal, but the appeal process delays payment and increases administrative costs. Worse, from a compliance perspective, repeated claims submitted without required PA can trigger medical review programs and potentially put your Medicare number at risk.

Does the 60-day PCD validity window mean we can batch submissions?

Yes, strategically. If you have multiple PCD orders for the same patient, one prior authorization is valid for 60 days. This allows you to batch approvals and manage cash flow more efficiently. However, document the approval number and validity dates in your billing system to avoid claims submitted after the validity period expires.

If we hit 90% affirmation, do we stop getting denials?

No. The 90% threshold gets you an exemption from the prior authorization requirement — meaning you can submit claims without obtaining PA first. But that does not mean every claim will be approved. Commercial payers and Medicaid will still review claims post-submission and may deny individual claims based on medical necessity or other reasons. The exemption simply removes the administrative step of pre-approval.